BDX vs EOLS · P/E 34, rev $21.84B vs rev $266.3M
Becton Dickinson and Company (BDX) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the BDX and EOLS stock pages for the full models.
Not investment advice.